Here’s a quick one recap on the state-level psychedelic bills under discussion, aside from Colorado’s measure regulate Implementation framework of the country – from May 2nd:

• Arizona: HB2489 or “The PTSD Treatment Act of 2023,” which states, “Any compound, mixture, or preparation” containing MDMA that is both FDA-approved and DEA-down and intended for the treatment of PTSD may be used in the State, was tacitly passed to the governor’s desk, where it was finally approved on April 28th.

• California: Sen. Wieners SB58 The legalization of the possession, preparation, acquisition, and transfer of certain amounts (between 2 and 15 grams) of natural psychedelics for personal and facilitated use of the substances has been approved by the Appropriations Committee and is now moving to the Senate on an expedited hearing, with further deliberation of the committee to be skipped , first reported marijuana moment.

• Minnesota: HF1884, Finally included in the large-scale omnibus health bill HF2930 in an amended version establishing a task force to address state legislative reform to legalize and regulate psychedelics medicine (particularly psilocybin, MDMA and LSD) has taken State House floor and is now scheduled to transition to a bicameral conference committee.

• Missouri: HB1154 to government research on psilocybin for depression, PTSD, substance use disorders and end of life care has gone through several iterations, changes, revisions and is now back on the formal House Perfection Calendar as of April 25th.

• Photo: Benzinga edit with photo by Alexander_Volkov and canbedone on Shutterstock.

• 
  

  ICYM Gasoline Capital of Psychedelics conference 2023

  
  

  Here is some EXCLUSIVE coverage from the second edition of the event:

• Johns Hopkins Professor: Psychedelic medicine could become messy, calls for ‘correct, intelligent, non-restrictive, but preventive’ prescriptions

• Investing in the unique growth market of psychedelics

• MDMA Therapy Experts Discuss Coming Soon…